Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
McKesson
Merck
US Department of Justice
Mallinckrodt
US Army
Moodys
Harvard Business School

Generated: April 21, 2018

DrugPatentWatch Database Preview

DEPO-TESTOSTERONE Drug Profile

« Back to Dashboard

When do Depo-testosterone patents expire, and what generic alternatives are available?

Depo-testosterone is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DEPO-TESTOSTERONE is testosterone cypionate. There are sixty-three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the testosterone cypionate profile page.
Drug patent expirations by year for DEPO-TESTOSTERONE
Pharmacology for DEPO-TESTOSTERONE
Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Synonyms for DEPO-TESTOSTERONE
(17beta)-3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate
(1S,2R,10R,11S,14S,15S)-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL 3-CYCLOPENTYLPROPANOATE
(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
053T944
17-(3-cyclopentyl-1-propionyl)-17beta-hydroxyandrost-4-en-3-one
17-(Cyclopentyl-1-oxopropoxy)androst-4-en-3-one, (17.beta.)-
17.beta.-Hydroxyandrost-4-en-3-one cyclopentylpropionate
17beta-Hydroxyandrost-4-en-3-one cyclopentylpropionate
3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate, (17.beta.)- #
3-oxoandrost-4-en-17beta-yl 3-cyclopentylpropanoate
58-20-8
AB0090519
AB01274709-01
AB2000228
AC1L9B3P
AKOS007930349
AKOS015895326
Andro-Cyp
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17.beta.)-
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17b)-
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17beta)-
BRN 3174363
C-21939
C08156
CC-34816
CHEBI:9463
CHEMBL1201101
CT0176
D00957
Dep-Test
depAndro 100
depAndro 200
Depo-Testadiol
Depo-testosterone (TN)
Depo-testosterone cyclopentylpropionate
Depo-Testosterone cypionate
Depovirin
Durandro
EINECS 200-368-4
HPFVBGJFAYZEBE-ZLQWOROUSA-N
Jectatest
LMST02020074
M0XW1UBI14
Malogen CYP
MolPort-003-959-637
NSC 9157
Pertestis
PL000354
SCHEMBL40862
T-Ionate-P.A
Testodrin prolongatum
Testosterone 17-beta-cypionate
Testosterone 17.beta.-cyclopentanepropionate
Testosterone 17.beta.-cyclopentylpropionate
Testosterone 17.beta.-cypionate
Testosterone 17beta-cyclopentanepropionate
Testosterone 17beta-cyclopentylpropionate
Testosterone 17beta-cypionate
Testosterone cyclopentanepropionate
Testosterone cyclopentylpropionate
TESTOSTERONE CYPIONATE
Testosterone cypionate (USP)
Testosterone cypionate [USP]
Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard
Testosterone, cyclopentanepropionate
Testosteronecypionate
UNII-M0XW1UBI14
W-105407
ZINC4097468

US Patents and Regulatory Information for DEPO-TESTOSTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-002 Approved Prior to Jan 1, 1982 AO RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-003 Approved Prior to Jan 1, 1982 AO RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Merck
Daiichi Sankyo
Chubb
Mallinckrodt
Queensland Health
Covington
Healthtrust
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.